AquaBounty Technologies Inc Stock News

AquaBounty Technologies Inc (AQB) shares closed 0.5% lower than its previous 52 week low, giving the company a market cap of $137M. The stock is currently down 7.6% year-to-date, down 78.6% over the past 12 months, and down 92.0% over the past five years. This week, the Dow Jones Industrial Average fell 1.4%, and the S&P 500 fell 1.6%. Trading Activity Trading volume this week was 211.3% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.8. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 119.6% The company's stock price performance over the past 12 months lags the peer average by 59.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

MAYNARD, Mass., Jan. 11, 2022 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (Nasdaq: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhanc

AquaBounty Technologies Inc (AQB) shares closed today at 1.0% above its 52 week low of $2.01, giving the company a market cap of $145M. The stock is currently down 2.4% year-to-date, down 75.6% over the past 12 months, and down 91.5% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 1.7%. Trading Activity Trading volume this week was 13.2% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.8. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -51.4% The company's stock price performance over the past 12 months lags the peer average by 44.4% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

MAYNARD, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (Nasdaq: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhanc

MAYNARD, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (NASDAQ: AQB ) ("AquaBounty" or the "Company"), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced that management will participate in the H.C. Wainwright BioConnect Conference taking place on January 10-13, 2022. Sylvia Wulf, Chief Executive Officer of AquaBounty, is scheduled to host a virtual presentation at the H.C. Wainwright BioConnect Conference as follows: H.C. Wainwright BioConnect Conference Date: Monday, January 10, 2022 Recorded Presentation Available After 7:00 a.m. Eastern time Webcast: https://journey.ct.events/view/48f54ac3-5739-41c5-8c77-d812c57614bb The recorded presentation will remain accessible at the webcast link above through April 10, 2022. For more information, please contact your H.C. Wainwright representative. About AquaBounty AquaBounty Technologies, Inc. (NASDAQ: AQB ) is a leader in aquaculture leveraging decades of technology expertise to deliver game changing solutions that solve global problems, while improving efficiency, sustainability and profitability.

MAYNARD, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (Nasdaq: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance

AquaBounty Technologies Inc (AQB) shares closed today at 1.0% above its 52 week low of $2.09, giving the company a market cap of $149M. The stock is currently down 75.9% year-to-date, down 77.3% over the past 12 months, and down 91.3% over the past five years. This week, the Dow Jones Industrial Average rose 2.6%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 41.2% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.9. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 96.2% The company's stock price performance over the past 12 months lags the peer average by 85.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Equities research analysts expect AquaBounty Technologies, Inc. (NASDAQ:AQB) to report sales of $960,000.00 for the current quarter, according to Zacks. Three analysts have provided estimates for AquaBounty Technologies earnings, with the lowest sales estimate coming in at $490,000.00 and the highest estimate coming in at $1.40 million. AquaBounty Technologies reported sales of $50,000.00 during the []

Analysts forecast that AquaBounty Technologies, Inc. (NASDAQ:AQB) will announce ($0.08) earnings per share for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for AquaBounty Technologies earnings. The highest EPS estimate is ($0.06) and the lowest is ($0.10). AquaBounty Technologies posted earnings of ($0.14) per share in the same quarter last []

Charles Schwab Investment Management Inc. grew its holdings in AquaBounty Technologies, Inc. (NASDAQ:AQB) by 529.6% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 132,265 shares of the companys stock after acquiring an additional 111,256 shares during the period. Charles Schwab Investment Management Inc.s holdings in AquaBounty Technologies were worth $709,000 at the end []

AquaBounty Technologies found using ticker (AQB) now have 4 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 12 and 4.5 and has a mean target at 7.38. With the stocks previous close at 2.79 this would indicate that there is a potential upside of 164.5%. The 50 day moving average now sits at 3.82 while the 200 day moving average is 5.25. The market cap for the company is $183m. You can visit the company''s website by visiting: /> [stock_market_widget type="chart" symbol="AQB" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] AquaBounty Technologies, a biotechnology company, focuses on improving productivity in the commercial aquaculture industry in the United States and Canada. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms and changed its name to AquaBounty Technologies in June 2004.

Analysts expect AquaBounty Technologies, Inc. (NASDAQ:AQB) to report sales of $960,000.00 for the current quarter, according to Zacks Investment Research. Three analysts have made estimates for AquaBounty Technologies earnings, with the highest sales estimate coming in at $1.40 million and the lowest estimate coming in at $490,000.00. AquaBounty Technologies posted sales of $50,000.00 during the []

3 penny stocks attracting attention from ARK Invest family of funds. The post 3 Penny Stocks Cathie Wood’s ARK Invest Bought In 2021, Will You? appeared first on Penny Stocks to Buy, Picks, News and

3 penny stocks attracting attention from ARK Invest family of funds. The post 3 Penny Stocks Cathie Wood's ARK Invest Bought In 2021, Will You?

AquaBounty Technologies found using ticker (AQB) have now 4 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 12 and 4.5 calculating the average target price we see 7.38. Given that the stocks previous close was at 3.12 this indicates there is a potential upside of 136.5%. The day 50 moving average is 3.94 and the 200 day moving average is 5.39. The market cap for the company is $175m. Company Website: /> [stock_market_widget type="chart" symbol="AQB" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] AquaBounty Technologies, a biotechnology company, focuses on improving productivity in the commercial aquaculture industry in the United States and Canada. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms and changed its name to AquaBounty Technologies in June 2004.